Cargando…
Transfemoral transcatheter aortic valve replacement for pure native aortic regurgitation: one-year outcomes of a single-center study
BACKGROUND: Evidence about safety and efficacy of transcatheter aortic valve replacement (TAVR) with the Venus A-Valve system (Venus Medtech, Hangzhou, China) remains limited for patients with pure native aortic regurgitation (PNAR). OBJECTIVES: The single-center study sought to report the one-year...
Autores principales: | Zheng, Hua-Jie, Cheng, Yong-Bo, Yan, Chao-Jun, Lin, De-Qing, Yu, San-Jiu, Li, Jun, He, Ping, Cheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311875/ https://www.ncbi.nlm.nih.gov/pubmed/37386379 http://dx.doi.org/10.1186/s12872-023-03329-1 |
Ejemplares similares
-
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation: Challenging Pathology Awaiting Specialized Devices
por: El-Gamel, Adam
Publicado: (2021) -
Transcatheter Aortic Valve Implantation for Pure Native Aortic Regurgitation: The Last Frontier
por: Tagliari, Ana Paula, et al.
Publicado: (2022) -
Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone
por: Tarantini, Giuseppe, et al.
Publicado: (2022) -
Outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation with the use of newer- vs. early-generation devices
por: Yin, Wei-Hsian, et al.
Publicado: (2022) -
Transcatheter aortic valve replacement in pure native aortic regurgitation: when off-label indications match the patient’s requirements
por: Madrazo-Shiordia, Javier A., et al.
Publicado: (2022)